Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$31,920
New position
Shares Held
114
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#891
of 1,044 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in LH
reported options exposure · as of Jun 30, 2026CallValue
$56,000
CallShares
200
PutValue
$280,000
PutShares
1,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Alphadyne Asset Management LP holds $368,833 across 2 Diagnostics & Research names. LH ranks #2 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
672 | $336,913 | |
| 2 | LH |
Labcorp Holdings Inc.
This page
|
114 | $31,920 |
All Filings in LH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $280,000 | 1,000 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $56,000 | 200 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $31,920 | 114 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||